Clinical Trial Update: Selenium in the Treatment of Arsenic Toxicity and Cancers [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating selenium for treating arsenic toxicity and arsenic-related cancers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arsenic Poisoning
• Arsenic Toxicity
• Arsenic-induced Cancer
• Arsenical Keratosis
• Arsenical Melanosis

Drugs mentioned

• Selenium (selenium)

Snippet

Sponsor: Texas Tech University | Conditions: Arsenical Melanosis, Arsenical Keratosis | Phase 3 | Status: COMPLETED